| ACC |
Adrenocortical carcinoma |
76 |
0.82 |
0.62 |
| BLCA |
Bladder Urothelial Carcinoma |
402 |
0.96 |
0.8 |
| BRCA |
Breast invasive carcinoma |
1070 |
1.6 |
0.0058 |
| CESC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
292 |
1 |
0.88 |
| CHOL |
Cholangio carcinoma |
36 |
1.4 |
0.48 |
| COAD |
Colon adenocarcinoma |
270 |
0.49 |
0.0042 |
| DLBC |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
46 |
1.6 |
0.49 |
| ESCA |
Esophageal carcinoma |
182 |
1.1 |
0.82 |
| GBM |
Glioblastoma multiforme |
162 |
0.71 |
0.056 |
| HNSC |
Head and Neck squamous cell carcinoma |
518 |
1 |
0.73 |
| KICH |
Kidney Chromophobe |
64 |
3.1 |
0.15 |
| KIRC |
Kidney renal clear cell carcinoma |
516 |
0.58 |
0.00062 |
| KIRP |
Kidney renal papillary cell carcinoma |
282 |
0.44 |
0.012 |
| LAML |
Acute Myeloid Leukemia |
106 |
1.2 |
0.6 |
| LGG |
Brain Lower Grade Glioma |
514 |
1.5 |
0.021 |
| LIHC |
Liver hepatocellular carcinoma |
364 |
0.95 |
0.77 |
| LUAD |
Lung adenocarcinoma |
478 |
1.2 |
0.14 |
| LUSC |
Lung squamous cell carcinoma |
482 |
1 |
0.89 |
| MESO |
Mesothelioma |
82 |
0.85 |
0.5 |
| OV |
Ovarian serous cystadenocarcinoma |
424 |
0.93 |
0.53 |
| PAAD |
Pancreatic adenocarcinoma |
178 |
1.2 |
0.34 |
| PCPG |
Pheochromocytoma and Paraganglioma |
182 |
1.7 |
0.55 |
| PRAD |
Prostate adenocarcinoma |
492 |
1.7 |
0.41 |
| READ |
Rectum adenocarcinoma |
92 |
0.41 |
0.085 |
| SARC |
Sarcoma |
262 |
1 |
0.91 |
| SKCM |
Skin Cutaneous Melanoma |
458 |
0.91 |
0.5 |
| STAD |
Stomach adenocarcinoma |
384 |
1.1 |
0.46 |
| TGCT |
Testicular Germ Cell Tumors |
138 |
0.34 |
0.33 |
| THCA |
Thyroid carcinoma |
510 |
1.4 |
0.48 |
| THYM |
Thymoma |
118 |
5.5 |
0.074 |
| UCEC |
Uterine Corpus Endometrial Carcinoma |
172 |
0.68 |
0.29 |
| UCS |
Uterine Carcinosarcoma |
56 |
1.1 |
0.83 |
| UVM |
Uveal Melanoma |
78 |
4.4 |
0.0038 |
